Company
Headquarters: Jakarta, Indonesia
Employees: 12,939
Rp21.665 Trillion
IDR as of July 1, 2025
US$1.34 Billion
| Company | Market Cap (USD) | 
|---|---|
| Lilly | $699.59 B | 
| Johnson & Johnson | $374.29 B | 
| AbbVie | $336.94 B | 
| Novo Nordisk | $309.91 B | 
| UnitedHealth Group | $279.90 B | 
PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. As of December 31, 2020, it operated 40 hospitals. The company was founded in 1999 and is based in Jakarta, Indonesia.
| Last Financial Reports Date | March 31, 2025 | 
| Revenue TTM | Rp6.703 T | 
| EBITDA | Rp1.287 T | 
| Gross Profit TTM | Rp2.203 T | 
| Profit Margin | 7.01% | 
| Operating Margin | 15.64% | 
| Quarterly Revenue Growth | -0.80% | 
PT Medikaloka Hermina Tbk has the following listings and related stock indices.
Stock: IDX: HEAL wb_incandescent